SCHEMBL4021787

SCHEMBL4021787

O=C(O)CNC(=O)c1ccc2nonc2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.68
ADORA2A P29274 1/20 0.68
ADORA2B P29275 1/20 0.68
ADORA1 P30542 1/20 0.68
KDM4E B2RXH2 2/20 0.52
MAPK1 P28482 1/20 0.52
EPHX2 P34913 1/20 0.51
MAPT P10636 2/20 0.50
HIF1A Q16665 1/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
SLC22A8 Q8TCC7 1/20 0.50
TAS1R3 Q7RTX0 1/20 0.48
TAS1R1 Q7RTX1 1/20 0.48
TAS1R2 Q8TE23 1/20 0.48
PTPRC P08575 2/20 0.48
CTSL P07711 1/20 0.48
PTPN13 Q12923 1/20 0.48
HDAC3 O15379 1/20 0.47
HDAC1 Q13547 1/20 0.47
CA1 P00915 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4016666 0.84 ADORA3 (0.59) ADORA3ADORA2AADORA2BADORA1KDM4E
SCHEMBL13753935 0.83 ADORA3 (0.65) ADORA3ADORA2AADORA2BADORA1KDM4E
SCHEMBL2834465 0.80 ADORA3 (0.61) ADORA3ADORA2AADORA2BADORA1KDM4E
SCHEMBL13081990 0.80 ADORA3 (0.62) ADORA3ADORA2AADORA2BADORA1KDM4E
SCHEMBL6028970 0.80 ADORA3 (0.62) ADORA3ADORA2AADORA2BADORA1KDM4E
SCHEMBL6028978 0.80 ADORA3 (0.62) ADORA3ADORA2AADORA2BADORA1KDM4E
SCHEMBL14027512 0.79 ADORA3 (0.76) ADORA3ADORA2AADORA2BADORA1KDM4E
SCHEMBL13248222 0.78 ADORA3 (0.56) ADORA3ADORA2AADORA2BADORA1KDM4E
SCHEMBL15841821 0.78 ADORA3 (0.59) ADORA3ADORA2AADORA2BADORA1KDM4E
SCHEMBL13056379 0.77 ADORA3 (0.55) ADORA3ADORA2AADORA2BADORA1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632851-B2 Benzo[1,2,5]oxadiazoles and benzol[1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers NOVARTIS AG (CH) 2009-12-15 US disclosed
EP-1613610-B1 BENZO 1,2,5 OXADIAZOLES AND BENZO 1,2,5 THIADIAZOLES USEFUL AS HISTOPATHOLOGICAL STAINING AGENTS, IMAGING AGENTS AND BIOMARKERS NOVARTIS AG (CH) 2009-07-01 EP disclosed
US-20060093551-A1 Benzo[1,2,5]oxadiazoles and benzol[1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers NOVARTIS AG (CH) 2006-05-04 US disclosed
EP-1613610-A1 BENZO 1,2,5 OXADIAZOLES AND BENZO 1,2,5 THIADIAZOLES USEFUL AS HISTOPATHOLOGICAL STAINING AGENTS, IMAGING AGENTS AND BIOMARKERS Novartis AG (CH) 2006-01-11 EP disclosed
WO-2004087684-A1 BENZO[1,2,5]OXADIAZOLES AND BENZO [1,2,5]THIADIAZOLES USEFUL AS HISTOPATHOLOGICAL STAINING AGENTS, IMAGING AGENTS AND BIOMARKERS NOVARTIS AG (CH) 2004-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060093551-A1 Benzo[1,2,5]oxadiazoles and benzol[1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers H1-3, MKI67, H1-5 ADORA3 2073/4885ADORA2A 4426/4885ADORA2B 3216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.